Total Payments
$318,477
2024 Payments
$45,330
Companies
47
Transactions
1,582
Medicare Patients
19,197
Medicare Billing
$2.0M
Payment Breakdown by Category
Other$241,725 (75.9%)
Consulting$37,104 (11.7%)
Food & Beverage$28,469 (8.9%)
Travel$10,883 (3.4%)
Education$295.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $229,565 | 128 | 72.1% |
| Consulting Fee | $37,104 | 21 | 11.7% |
| Food and Beverage | $28,469 | 1,334 | 8.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $12,160 | 9 | 3.8% |
| Travel and Lodging | $10,883 | 84 | 3.4% |
| Education | $295.95 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $68,488 | 182 | $0 (2024) |
| Dermavant Sciences, Inc. | $64,754 | 79 | $0 (2024) |
| Incyte Corporation | $55,743 | 94 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $41,756 | 106 | $0 (2024) |
| Lilly USA, LLC | $30,502 | 55 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $15,280 | 60 | $0 (2024) |
| UCB, Inc. | $8,273 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $6,339 | 264 | $0 (2024) |
| GENZYME CORPORATION | $4,548 | 42 | $0 (2024) |
| Journey Medical Corporation | $4,474 | 63 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,330 | 182 | Incyte Corporation ($25,839) |
| 2023 | $100,204 | 263 | Dermavant Sciences, Inc. ($40,966) |
| 2022 | $61,800 | 229 | Dermavant Sciences, Inc. ($18,421) |
| 2021 | $14,631 | 200 | Novartis Pharmaceuticals Corporation ($3,372) |
| 2020 | $22,930 | 166 | Novartis Pharmaceuticals Corporation ($10,653) |
| 2019 | $33,477 | 271 | Novartis Pharmaceuticals Corporation ($13,010) |
| 2018 | $28,646 | 178 | Novartis Pharmaceuticals Corporation ($12,416) |
| 2017 | $11,459 | 93 | PFIZER INC. ($9,960) |
All Payment Transactions
1,582 individual payment records from CMS Open Payments — Page 1 of 64
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.87 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.28 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $117.38 | General |
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.66 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: Immunology | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.97 | General |
| Category: Immunology | ||||||
| 11/20/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 11/13/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 5,303 | 8,978 | $1.3M | $563,005 |
| 2022 | 29 | 5,035 | 7,876 | $1.0M | $519,928 |
| 2021 | 31 | 4,704 | 7,884 | $1.1M | $527,834 |
| 2020 | 29 | 4,155 | 6,974 | $817,520 | $382,007 |
Total Patients
19,197
Total Services
31,712
Medicare Billing
$2.0M
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,767 | 2,772 | $406,800 | $187,053 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 872 | 1,222 | $239,800 | $118,265 | 49.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 808 | 1,231 | $153,875 | $64,164 | 41.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 260 | 272 | $47,600 | $23,871 | 50.1% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 45 | 47 | $24,910 | $16,658 | 66.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 90 | 92 | $36,800 | $15,533 | 42.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 140 | 161 | $28,175 | $15,375 | 54.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 50 | 53 | $23,850 | $14,627 | 61.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 84 | 98 | $26,950 | $13,951 | 51.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 512 | 2,323 | $91,755 | $13,516 | 14.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 144 | 144 | $28,450 | $12,102 | 42.5% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 44 | 47 | $17,625 | $11,189 | 63.5% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 16 | 18 | $10,800 | $6,629 | 61.4% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 56 | 63 | $17,640 | $6,386 | 36.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 42 | 44 | $21,780 | $5,781 | 26.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 35 | 36 | $20,340 | $4,872 | 24.0% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $5,795 | $3,325 | 57.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 30 | $6,750 | $3,157 | 46.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 62 | $5,925 | $2,666 | 45.0% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 17 | 18 | $9,000 | $2,656 | 29.5% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 28 | 29 | $5,365 | $2,501 | 46.6% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $5,415 | $2,148 | 39.7% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $5,665 | $2,110 | 37.3% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 11 | 11 | $6,050 | $2,012 | 33.3% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 21 | 22 | $3,190 | $1,616 | 50.7% |
About Dr. Aaron Fuchs, M.D
Dr. Aaron Fuchs, M.D is a Procedural Dermatology healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2009. The National Provider Identifier (NPI) number assigned to this provider is 1124261177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Fuchs, M.D has received a total of $318,477 in payments from pharmaceutical and medical device companies, with $45,330 received in 2024. These payments were reported across 1,582 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($229,565).
As a Medicare-enrolled provider, Fuchs has provided services to 19,197 Medicare beneficiaries, totaling 31,712 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Procedural Dermatology
- Location Falls Church, VA
- Active Since 04/07/2009
- Last Updated 02/08/2022
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1124261177
Products in Payments
- VTAMA (Drug) $64,754
- OPZELURA (Drug) $54,023
- COSENTYX (Biological) $41,654
- CIBINQO (Drug) $34,962
- EUCRISA (Drug) $32,485
- TALTZ (Drug) $24,412
- DUOBRII (Drug) $14,865
- DUPIXENT (Biological) $6,427
- Tremfya (Drug) $4,181
- ENSTILAR (Drug) $2,457
- Cimzia (Drug) $1,733
- TargaDox (Drug) $1,452
- TREMFYA (Drug) $1,383
- ADBRY (Biological) $1,357
- Accutane (Drug) $1,121
- Qbrexza (Drug) $1,110
- SKYRIZI (Biological) $1,068
- REMICADE (Biological) $669.79
- Humira (Biological) $628.22
- RINVOQ (Biological) $533.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.